Jenburkt Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Jenburkt Pharmaceuticals Ltd. from all sources in a single place.

Jenburkt Pharmaceuticals Ltd.

13 Aug 2025

1106.80

-1.35%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication for Standalone Unaudited Financial Results for the quarter ended 30th June, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

12 Aug 2025

1106.80

-1.35%

Result

Jenburkt Pharmaceuticals Ltd - 524731 - Standalone Unaudited Financial Results For The Quarter Ended On 30Th …

BSE India

Standalone Unaudited Financial Results for the Quarter ended on 30th June, 2025.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	37.58	42.93	33.94	-12.5%	10.7%
Operating Profit Qtr	8.96	10.86	9.29	-17.5%	-3.6%
Net Profit Qtr	7.79	8.54	7.42	-8.8%	5.0%
Earning Per Share Adjusted latest Qtr	17.66	19.34	16.80	-8.7%	5.1%

* Standalone data

Detailed Results

Jenburkt Pharmaceuticals Ltd.

12 Aug 2025

1106.80

-1.35%

Board Meeting

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Outcome of the Board Meeting held today on 12th August, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

01 Aug 2025

1106.80

-1.35%

Board Meeting

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial …

BSE India

Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve standalone unaudited financial results for the quarter ended on 30th June, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

18 Jul 2025

1106.80

-1.35%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Secretarial Auditor of the Company.

pdf

Jenburkt Pharmaceuticals Ltd.

18 Jul 2025

1106.80

-1.35%

AGM

Jenburkt Pharmaceuticals Ltd - 524731 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Submission of Consolidated Voting Results and Scrutinizer''s Report on all the resolutions as set out in the notice convening the 40th AGM of the Company held on 18th July, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

18 Jul 2025

1106.80

-1.35%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Proceedings Of The 40Th Annual General Meeting Of The Company …

BSE India

Proceedings of the 40th Annual General Meeting of the Company held on today i.e. 18th July, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

18 Jul 2025

1106.80

-1.35%

AGM

Jenburkt Pharmaceuticals Ltd - 524731 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Summary of the proceedings of the 40th Annual General Meeting of the Company held on 18th July, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

09 Jul 2025

1106.80

-1.35%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations, 2018 for the quarter ended on 30.06.2025

pdf

Jenburkt Pharmaceuticals Ltd.

23 Jun 2025

1106.80

-1.35%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication in pursuance of Rule 20(4) of the companies (Management and Administration) Rules, 2014, in connection with the 40th AGM of the Company.

pdf

Is Jenburkt Pharmaceuticals Ltd. worth buying?

28 Votes:

Buy 64.29%

Sell 21.43%

Hold 14.29%